Henry Schein, Inc. $HSIC Shares Purchased by Gamco Investors INC. ET AL

Gamco Investors INC. ET AL boosted its position in Henry Schein, Inc. (NASDAQ:HSIC) by 2.0% during the second quarter, Holdings Channel.com reports. The institutional investor owned 362,195 shares of the company’s stock after purchasing an additional 7,225 shares during the period. Gamco Investors INC. ET AL’s holdings in Henry Schein were worth $26,458,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently bought and sold shares of HSIC. Vanguard Personalized Indexing Management LLC lifted its stake in Henry Schein by 3.5% during the 2nd quarter. Vanguard Personalized Indexing Management LLC now owns 4,669 shares of the company’s stock valued at $341,000 after acquiring an additional 157 shares during the period. Equitable Trust Co. raised its holdings in shares of Henry Schein by 3.1% during the second quarter. Equitable Trust Co. now owns 5,317 shares of the company’s stock worth $388,000 after purchasing an additional 158 shares during the last quarter. CW Advisors LLC raised its holdings in shares of Henry Schein by 2.8% during the second quarter. CW Advisors LLC now owns 5,913 shares of the company’s stock worth $432,000 after purchasing an additional 163 shares during the last quarter. TD Asset Management Inc lifted its position in Henry Schein by 0.8% during the second quarter. TD Asset Management Inc now owns 22,016 shares of the company’s stock valued at $1,608,000 after purchasing an additional 164 shares during the period. Finally, Radnor Capital Management LLC boosted its holdings in Henry Schein by 1.6% in the second quarter. Radnor Capital Management LLC now owns 11,415 shares of the company’s stock valued at $834,000 after purchasing an additional 180 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analyst Ratings Changes

HSIC has been the subject of a number of recent research reports. Evercore ISI lifted their price objective on Henry Schein from $83.00 to $90.00 and gave the company an “outperform” rating in a research note on Wednesday, November 5th. Wall Street Zen upgraded Henry Schein from a “hold” rating to a “buy” rating in a research report on Saturday, November 8th. Weiss Ratings reissued a “hold (c)” rating on shares of Henry Schein in a report on Thursday. Morgan Stanley raised their price objective on shares of Henry Schein from $55.00 to $58.00 and gave the stock an “underweight” rating in a research note on Wednesday, November 5th. Finally, Wells Fargo & Company boosted their target price on shares of Henry Schein from $70.00 to $76.00 and gave the company an “equal weight” rating in a research note on Wednesday, November 5th. Five equities research analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $76.17.

Henry Schein Stock Up 0.4%

Shares of HSIC opened at $73.62 on Friday. The firm has a market cap of $8.67 billion, a P/E ratio of 23.30, a PEG ratio of 2.26 and a beta of 0.89. Henry Schein, Inc. has a 12 month low of $60.56 and a 12 month high of $82.49. The stock’s 50 day moving average is $68.30 and its two-hundred day moving average is $69.44. The company has a current ratio of 1.40, a quick ratio of 0.79 and a debt-to-equity ratio of 0.54.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, November 4th. The company reported $1.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.27 by $0.11. The firm had revenue of $3.34 billion for the quarter, compared to analyst estimates of $3.28 billion. Henry Schein had a return on equity of 14.76% and a net margin of 3.02%.Henry Schein has set its FY 2025 guidance at 4.880-4.960 EPS. Analysts predict that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.